Search clinical trials for: c-Met mutations or amplifications
Total 205652 results
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
Dr Cipto Mangunkusumo General HospitalCompletedColorectal Cancer | APC Gene Mutation | TP53 Gene Mutation | PIK3CA Gene Mutation | KRAS Mutation-Related Tumors | MLH1 Gene MutationIndonesia
-
Novartis PharmaceuticalsCompletedCancerFrance, Australia, United States, Canada, United Kingdom
-
Rush University Medical CenterCompleted
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Rhythm Pharmaceuticals, Inc.CompletedPOMC Deficiency Obesity | PCSK1 Deficiency Obesity | LEPR Deficiency ObesityTurkey
-
AGO Research GmbHCompleted
-
Columbia UniversityCold Spring Harbor LaboratoryCompletedPancreatic CancerUnited States
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
AstraZenecaiOMEDICO AG, Freiburg, GermanyCompletedCarcinoma, Non-Small-Cell LungGermany
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
Kura Oncology, Inc.CompletedThyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant TumorSpain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
TRPHARMKlinar CRO; Damagen Genetic Diagnostic CenterEnrolling by invitationXanthomatosis, CerebrotendinousTurkey
-
NYU Langone HealthGenzyme, a Sanofi CompanyCompleted
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Colorectal CancerUnited States
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Samsung Medical CenterCompleted
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Hellenic Cooperative Oncology GroupCompletedPancreatic Cancer | Hereditary Cancer | Predisposition, Genetic | Germline Mutation AbnormalityGreece
-
Yale UniversityCompleted
-
National Cancer Institute (NCI)CompletedStage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | KRAS NP_004976.2:p.G12RUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene MutationUnited States
-
Nantes University HospitalTerminatedNon-atopic Asthma | Genetic StudyFrance
-
Columbia UniversityMayo ClinicCompleted
-
National Taiwan University HospitalNovartisUnknownMetastatic Breast CancerTaiwan
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertrophic CardiomyopathyUnited States, Canada
-
University of LiegeEGID, LilleUnknown
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Peking University People's HospitalUnknownSafety Issues | Efficacy, SelfChina
-
University Hospital, MontpellierCompleted
-
National Cancer Institute (NCI)CompletedLi-Fraumeni SyndromeUnited States
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisNetherlands, Italy, United Kingdom
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
Poitiers University HospitalCompletedPancreatic Cancer | Circulating Tumor DNA | KRAS Mutation-Related Tumors
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.TerminatedLiver TransplantationUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedCystic FibrosisUnited States
-
University of MinnesotaCompletedUrticaria Pigmentosa | Cutaneous MastocytosisUnited States
-
National Cancer Institute (NCI)Terminated
-
AstraZenecaCompletedOvarian CancerUnited Arab Emirates
-
IRCCS San RaffaeleUnknownPancreas AdenocarcinomaItaly